The effect of immunothrapeutic g2 vaccine on treatment of oral lichen planus

Phase 3

• Conditions: Oral Lichen Planus.; Other Lichen Planus; L00-L99

• Registration Number: IRCT138810112950N1
• Lead Sponsor: Dr Mohaghegh Biotechnology Reaserch Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

atrophic-erosive oral lichen planus

Exclution criteria:systemic disease-breast feeding and pregnant weman-use of corticosteroids in the last month

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain and burning sensation asking from pateints. Timepoint: Once a week for 12 weeks. Method of measurement: Visual analoge scle-0=no pain and burning and 10 the most pain and burning.;CD4 and CD8 count. Timepoint: before injections-end of injections(13th week). Method of measurement: number of CD4 and CD8 in peripheral blood(by flowcytometry).

Secondary Outcome Measures

Name	Time	Method
Treatment oral lichen planus lesions(reduce size of lesions). Timepoint: Before injection-sixth week-twelveth week. Method of measurement: Ruler(mm2).